medigraphic.com
Órgano Oficial de la Asociación Mexicana de Infectología Pediátrica y la SLIPE.

2012, Number 100

<< Back Next >>

Rev Enfer Infec Pediatr 2012; 25.26 (100)

Late neonatal sepsis by group B streptococcus. Transmission through breastfeeding

Bernardino CM, Ortiz MR, Álvarez FB, Cabanillas VL, García HP, Ramos AJT

Language: Spanish
References: 18
Page: 132-136
PDF size: 352.87 Kb.


ABSTRACT

Group B streptococcus (GBS) or Streptococcus agalactiae is a major cause of bacterial infection in the newborn, with two clinical forms: early and late-onset infection. Of the latter we know different transmission mechanisms: horizontal, nosocomial or community acquired. There are few cases reported in the literature in which the ingestion of breast milk colonized by GBS was the cause of late infection in the newborn. In this paper, we report a case of late-onset sepsis and meningitis due to GBS transmitted through breast milk in a mother without mastitis. We will also review the pathogenesis of this disease and the controversy about treatment or withdrawal of maternal breastfeeding in these cases.


REFERENCES

  1. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002 Aug; 51 (RR-11):1-22.

  2. Prieto Tato LM, Gimeno Diaz de Atauri A. Aracil Santos J, Omeñaca Teres F, del Castillo Martin F, de Jose Gómez MI. Infección tardía por estreptococo del grupo B: experiencia en un hospital de tercer nivel (2000-2006). An Pediatr (Barc). 2008 Mar; 68(3):239-43.

  3. Kotiw M, Zhang GW, Daggard G , Reiss-Levy E , Tapsall JW, Numa A. Late-onset and recurrent Neonatal group B streptococcal disease associated with breast- milk transmission. Pediatr Dev Pathol 2003 May-Jun 6(3):251-6.

  4. Olver William J, Bond David W, Boswell Tim C, Watkin SL. Neonatal group B streptococcal disease associated with infected breast milk. Arch Dis Child Fetal Neonatal Ed. 2000;83:48-9.

  5. Arias-Camison JM. Late onset group B streptococcal infection from maternal expressed breast milk in a very low birth weight infant. J Perinatol 2003 Dec; 23(8):691-2.

  6. Godambe S, Shah PS, Shah V. Breast milk as a source of late onset neonatal sepsis Pediatr Infect Dis J. 2005 Apr; 24(4):381-2.

  7. Dinger J, Muller D, Pargac N, Schwarze R. Breast milk transmission of group B streptococcal infection. Pediatr Infect Dis J. 2002 Jun;21(6):567-8.

  8. Edwards MS, Muñoz FM, Baker CJ. Antibodies to type III group B streptococcal polysaccharide in breast milk. Pediatr Infec Dis J 2004 Oct;23(10):961-3 .

  9. Fluegge K, Supper S, Siedler A, Berner R. Serotype distribution of invasive group B streptococcal isolates in infants: results from a nationwide active laboratory surveillance study over 2 years in Germany. Clin Infect Dis 2005 Mar 1;40(5):760-3.

  10. Weisner AM, Johnson AP, Lamagni TL, Arnold E, Warner M, Heath PT et al. Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin Infect Dis 2004 May 1;38(9):1203-8.

  11. Kubin V, Mrastikova H, Paulova M, Motlova J, Franek J. Group B streptococci in the milk of lactating mothers. Zentralbl Bakteriol Mikrobiol Hyg 1987 Jun;265(1-2):210-7.

  12. Baker CJ, Edwards MS. Group B streptococcal conjugate vaccines. Arch Dis Child. 2003 May;88(5):375-8.

  13. Verani JR, Schrag SJ. Group B streptococcal disease in infants: progress in prevention and continued challenges. Clin Perinatol. 2010 Jun;37(2):375-92.

  14. Edwards MS. Group B streptococcal conjugate vaccine: a timely concept for which the time has come. Hum Vaccin. 2008 Nov-Dec;4(6):444-8.

  15. Kasper DL, Paoletti LC, Wessels MR, Guttormsen HK, Carey VJ, Jennings HJ, et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest. 1996 Nov 15;98(10):2308-14.

  16. Baker CJ, Rench MA, McInnes P. Immunization of preg- nant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine. 2003 Jul 28;21(24):3468-72.

  17. Baker CJ, Paoletti LC, Wessels MR, Guttormsen HK, Rench MA, Hickman ME, et al. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis. 1999 Jan;179(1):142-50.

  18. Baker CJ, Paoletti LC, Rench MA, Guttormsen HK, Carey VJ, Hickman ME, et al. Use of capsular polysaccharide- tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women.J Infect Dis. 2000 Oct;182(4):1129-38.




2020     |     www.medigraphic.com